Jiangsu Kangyuan Pharmaceutical Co., Ltd. 2023 Equity Distribution Implementation Notice
Legal Opinion of Jiangsu Century Tongren Law Firm on the implementation of differentiated dividends in the 2023 profit distribution of Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on adjusting the dividend amount per share of the 2023 profit distribution plan
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the implementation of repurchase and cancellation of some restricted shares
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the progress of repurchasing the company's shares through centralized bidding transactions
Legal Opinion of Jiangsu Century Tongren Law Firm on the implementation of the 2022 Restricted Stock Incentive Plan of Jiangsu Kangyuan Pharmaceutical Co., Ltd. to repurchase and cancel some restricted stocks
Resolutions of the 9th Interim Meeting of the Eighth Board of Directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd. and Announcement on Extending the Implementation Period for Repurchase Shares and Adjusting the Maximum Price Limit for Repurchase Shares
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on receiving the approval notice for the clinical trial of Shichimi Fatty Liver Granules
Announcement on short-term transactions and apologies for spouses of independent directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd.
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on receiving a notice of approval for the clinical trial of Qiangqin granules
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the resignation of the director and secretary of the board of directors
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on the appointment of a deputy general manager
Announcement of Jiangsu Kangyuan Pharmaceutical Co., Ltd. on changing the registered capital, increasing the scope of business and amending the “Articles of Association”
Constitution of Jiangsu Kangyuan Pharmaceutical Co., Ltd. (draft)
Announcement of Resolutions of the Eighth Meeting of the Eighth Board of Directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd
Jiangsu Kangyuan Pharmaceutical Co., Ltd. Independent Director Annual Report Work System (Revised in April 2024)
Jiangsu Kangyuan Pharmaceutical Co., Ltd. Independent Director Work System (Draft)
Rules of procedure for the board of directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd. (draft)
Working Rules for the Special Meeting of Independent Directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd. (April 2024)
Working Rules of the Audit Committee of the Board of Directors of Jiangsu Kangyuan Pharmaceutical Co., Ltd. (Revised in April 2024)
No Data